Biofarm SA BIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 10.83
- Price/Sales
- 3.09
- Dividend Yield (Trailing)
- 3.70%
- Dividend Yield (Forward)
- 3.83%
- Total Yield
- 3.69%
Company Profile
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 402
- Website
- https://www.biofarm.ro
Comparables
Valuation
|
Metric
|
BIO
|
300194
|
047920
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.83 | 17.75 | — |
Price/Book Value | 1.90 | 1.22 | 11.01 |
Price/Sales | 3.09 | 1.93 | 6.63 |
Price/Cash Flow | 11.85 | 9.69 | — |
Price/Earnings
BIO
300194
047920
Financial Strength
|
Metric
|
BIO
|
300194
|
047920
|
|---|---|---|---|
Quick Ratio | 3.93 | 1.18 | 1.03 |
Current Ratio | 4.90 | 1.77 | 1.46 |
Interest Coverage | 917,028.68 | 10.96 | −0.64 |
Quick Ratio
BIO
300194
047920
Profitability
|
Metric
|
BIO
|
300194
|
047920
|
|---|---|---|---|
Return on Assets (Normalized) | 15.62% | 0.94% | −13.74% |
Return on Equity (Normalized) | 18.88% | 1.40% | −23.44% |
Return on Invested Capital (Normalized) | 17.35% | 1.12% | −9.92% |
Return on Assets
BIO
300194
047920
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dczrjpjcsv | Kgkx | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Srnxwmbbw | Pdvppf | $72.0 Bil | |
HLN
| Haleon PLC ADR | Xvqmscbdc | Rpzpf | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nlyddzmwr | Ppwvc | $17.9 Bil | |
VTRS
| Viatris Inc | Kypgjpmtd | Mknd | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xzsghjr | Qcx | $11.7 Bil | |
CTLT
| Catalent Inc | Gswbtpvc | Fxmcxl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Kqswvvzsn | Btzt | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Sxrvgkrz | Kzsg | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hjxjjvpt | Kdnwzdb | $3.5 Bil |